# Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage

> **NCT04891861** · PHASE3 · UNKNOWN · sponsor: **University of Texas at Austin** · enrollment: 100 (estimated)

## Conditions studied

- Anticoagulants; Increased

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT04891861
- **Lead sponsor:** University of Texas at Austin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04891861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04891861, "Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04891861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*